Fluocinolone Acetonide NDC 0713-0223

NDC codes

FDA NDC Directory

Product NDC (as listed)0713-0223Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00713-0223Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0713-0223-15	00713022315	1 TUBE in 1 CARTON (0713-0223-15) / 15 g in 1 TUBEMarketed from Jul 26, 1988
0713-0223-60	00713022360	1 TUBE in 1 CARTON (0713-0223-60) / 60 g in 1 TUBEMarketed from Jul 26, 1988

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinolone Acetonide
Generic name (nonproprietary): fluocinolone acetonide
Active ingredients: Fluocinolone acetonide — .1 mg/g
Dosage form: Cream
Route: Topical
Labeler: Cosette Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 089526
Marketing start: Jul 26, 1988
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0713-0223_0abbbbe6-b694-1260-e063-6294a90a6f81SPL ID 0abbbbe6-b694-1260-e063-6294a90a6f81SPL set ID de5b78ab-ff79-3e0f-cad4-ecab11ebbdcdRxCUI 1191256, 1191302, 1191315UNII 0CD5FD6S2M
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400713022315 followed by a unit qualifier and the quantity

Package 00713-0223-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 22, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)